ArticleBMC chemistry2026
A dual-matrix analytical framework integrating bio-inspired machine learning and Sobol-optimized UV spectrophotometry for five-analyte quantification: comprehensive sustainability assessment.
Article in BMC chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Eco-friendly spectrofluorimetric determination of fenbendazole in pharmaceutical, plasma, and milk samples using erythrosine B as a fluorescent probe.RSC advances · 2026Article
- Cyclodextrin nanosponges enhance the oral pharmacokinetics and antiplatelet efficacy of prasugrel hydrochloride in Wistar rats.Naunyn-Schmiedeberg's archives of pharmacology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The development of environmentally sustainable analytical methodologies capable of resolving highly overlapped multicomponent systems remains an important challenge in modern analytical chemistry. UV spectrophotometry offers several practical advantages, including minimal solvent-consumption, rapid analysis, low operational cost, and instrumental simplicity; however, its quantitative application is often constrained by severe spectral-overlap among analytes. In the present study, a dual-matrix chemometric framework was developed for the simultaneous determination of five spectrally overlapping analytes-hydrochlorothiazide (HCD), losartan potassium (LOS), ramipril (RAP), N-nitrosodiethylamine (NDA), and toluene (TLN)-in pharmaceutical formulations and fortified human plasma samples. The proposed methodology integrates a five-factor, five-level multilevel experimental design for calibration, Sobol quasi-random sampling for external validation, and Firefly Algorithm-optimized Partial Least Squares (FA-PLS) modeling for adaptive wavelength selection and multivariate calibration. The developed models demonstrated excellent analytical performance. For pharmaceutical formulations, mean recoveries ranged from 99.68 to 100.57%, with RMSEP values between 0.037 and 0.094 µg/mL. For fortified human plasma samples, mean recoveries ranged from 98.18 to 98.97%, with RMSEP values between 0.059 and 0.146 µg/mL, demonstrating the feasibility of the proposed approach under biologically relevant matrix conditions. The environmental profile of the proposed methodology was comprehensively evaluated using multiple complementary tools, including NEMI, ComplexGAPI, AGREE, the Multicolor Assessment Tool, carbon footprint estimation, and the Need-Quality-Sustainability index. Collectively, these assessments confirmed the favorable greenness and overall sustainability characteristics of the developed spectrophotometric approach. To the best of our knowledge, no previous UV spectrophotometric chemometric method has been reported for the simultaneous determination of LOS, RAP, and HCD in the presence of both NDA and TLN within a single analytical workflow without a prior separation step. The proposed dual-matrix FA-PLS framework demonstrates that UV spectrophotometry, when coupled with advanced chemometric optimization and statistically designed calibration strategies, can provide an accurate, sensitive, and environmentally sustainable platform for multicomponent pharmaceutical analysis and proof-of-concept application to biological matrices.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.